COPD

The European Respiratory Society and the American Thoracic Society have conducted a comprehensive review of evidence of managing exacerbations of chronic obstructive pulmonary disease in order to create a guideline of clinical recommendations.

A new collaboration between the Duke Clinical Research Institute, Duke University’s MURDOCK Study, and Boehringer Ingelheim Pharmaceuticals Inc will try to better understand how chronic obstructive pulmonary disease progresses in the real world.

Patients with chronic obstructive pulmonary disease see benefits from physical activity (PA); however, there are several barriers that limit participation in PA in a primary care setting.

Palliative care can help alleviate the suffering and symptoms that go along with serious disease, making it an important component when caring for complex, high-need patients, said Allison Silvers, vice president of payment and policy at the Center to Advance Palliative Care.

The majority of costs associated with chronic obstructive pulmonary disease (COPD) are associated with hospitalizations, and a new study in the International Journal of COPD set out to determine the exact drivers of high costs among hospitalized patients with COPD.

Using patient-reported outcomes and data on healthcare utilization, researchers from the Yale School of Medicine have been able to compare the health burden of asthma—COPD overlap syndrome with asthma or chronic obstructive pulmonary disease (COPD) alone.

For patients with chronic obstructive pulmonary disease (COPD), catching a cold is often more than just an annoyance; their risk of experiencing COPD symptom exacerbation rises 30-fold when they exhibit signs of a cold.

Home health beneficiaries with diabetes using paid supplementary caregivers had 68% higher hazards of readmission due to urinary tract infection than those with unpaid supplementary caregivers.

Patients receiving postdischarge care from pharmacists had a 28% lower risk of readmission at 30 days and a 31.9% lower risk at 180 days compared with usual care.

Patients with chronic obstructive pulmonary disease have a higher risk of falls, which a new study suggests could be explained by their altered walking patterns compared with healthy controls.

Except in cases of critical illness, the intensive care unit may not be the best place for patients experiencing a flare-up of heart failure or their chronic obstructive pulmonary disease or even having a heart attack.

A study of patients with chronic obstructive pulmonary disease worldwide found that higher self-reported symptom burden was associated with more severe impairment of work and activities, as well as increased utilization of healthcare services.

Weill Cornell Medicine and Boehringer Ingelheim have announced a collaboration that will investigate novel approaches to treating chronic respiratory disease.

A recent literature review confirmed that adult offspring of people with chronic obstructive pulmonary disease are at higher risk of being diagnosed with the disease themselves.

A study of patients with chronic obstructive pulmonary disease (COPD) treated at a Veterans Administration hospital in New York found an unexpected relationship: the veterans who were undertreated according to treatment guidelines had lower rates of COPD exacerbation events.

Since patients with COPD often have other comorbidities, researchers sought to understand patient adherence to maintenance COPD medications and adherence to treat other chronic conditions.

As the prevalence of chronic obstructive pulmonary disease increases, self-management will become increasingly important. However, a new study has highlighted the difficulties of embedding self-management into routine care.

Although chronic obstructive pulmonary disease (COPD) remains a leading cause of death around the world, the reason for why patients with COPD lose the ability to repair damage to their lungs is poorly defined. However, researchers at the Helmholtz Zentrium München may now have an idea of why this happens.

A study on gender and racial inequalities in the prevalence of chronic obstructive pulmonary disease among non-smokers found that black Americans and women are at higher risk, possibly due to a combination of biological and social factors.

Innovative funding models like value-based payments can change providers’ incentives and drive them to seek solutions like palliative care, said Allison Silvers, vice president of payment and policy at the Center to Advance Palliative Care.

According to CDC’s Morbidity and Mortality Weekly Report, the cigarette smoking rate of adults in the United States has seen a significant drop during the decade from 2005 to 2015.

The hotspotting technique that Camden Coalition of Healthcare Providers uses to care for complex patients shifts away from breaking people into segments based on disease, and looks at the whole make up of a person, considering every disease or social complexity that may be in effect, explained Renee Murray, associate clinical director of Care Management Initiatives at Camden Coalition.

Barring major advances in prevention, diagnosis, and treatment of chronic obstructive pulmonary disease (COPD), hospitalizations for the disease will increase by more than 150% over the next 15 years in developed countries

Once smokers develop chronic obstructive pulmonary disease, quitting may not improve smokers’ lung function; thus, smokers should quit as early as possible to have the greatest chance of reversing lung damage.

Using longitudinal Medicare claims data, this study quantified the association of the Medicare Part D coverage gap with medication adherence among beneficiaries with chronic obstructive pulmonary disease.

Steven D. Pearson, MD, president of the Institute for Clinical and Economic Review, discussed the specialty conditions that are having the biggest impact on overall healthcare expenditures and pharmaceutical spending.

Patients with chronic obstructive pulmonary disease (COPD) who engage in greater amounts of physical activity in the 12 months prior to hospitalization for COPD have a lower risk of death in the year following discharge.